Tandem Diabetes Care Inc (TNDM)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	-96,025	-126,782	-136,492	-141,453	-222,611	-208,461	-224,470	-203,751	-94,593	-67,933	-13,169	5,895	15,566	21,758	6,556	-24,559	-34,382	-48,730	-42,223	-16,628
Revenue (ttm)	US$ in thousands	1,059,521	973,669	796,002	770,009	747,718	771,424	790,349	794,694	801,218	790,712	765,792	737,669	702,799	660,868	604,844	541,941	498,830	439,163	410,217	394,236
Net profit margin		-9.06%	-13.02%	-17.15%	-18.37%	-29.77%	-27.02%	-28.40%	-25.64%	-11.81%	-8.59%	-1.72%	0.80%	2.21%	3.29%	1.08%	-4.53%	-6.89%	-11.10%	-10.29%	-4.22%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-96,025K ÷ $1,059,521K
= -9.06%

The net profit margin of Tandem Diabetes Care Inc has shown fluctuations over the period from March 31, 2020, to December 31, 2024. The company experienced negative net profit margins in most quarters, indicating that its profits were insufficient to cover its expenses and taxes. The margin improved slightly in the later quarters of June 30, 2021, and September 30, 2021, turning positive briefly. However, the trend reversed back to negative margins in subsequent periods, reaching its lowest point at -29.77% by December 31, 2023.

These negative net profit margins suggest that the company faced challenges in generating profits relative to its revenue during these periods. The decreasing trend in margins from March 31, 2024, to December 31, 2024, may indicate ongoing operational or financial difficulties impacting the company's bottom line. It would be essential for investors and stakeholders to monitor further financial reports to assess if the company can improve its profitability and sustainability in the future.